More on BBOT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:BBOT)
Delayed: 7.75 +0.29 (3.89%)
Prev. Close $7.46  
Open$7.46 
52 Wk High$ 
52 Wk Low$ 
Day High$7.82 
Day Low$7.44 
P/E N/A  
EPS$ 
Volume227,617 

Friends, Peers and Foes (?): ERAS RVMD (more...)

May 12, 2026 05:03 PM BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress
May 12, 2026 04:13 PM Form 4 BridgeBio Oncology Thera For: May 10 Filed by: Elmelech Idan
May 12, 2026 04:12 PM Form 4 BridgeBio Oncology Thera For: May 10 Filed by: Beltran Pedro
May 12, 2026 04:05 PM BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 11, 2026 05:17 AM Canaccord Starts BridgeBio Oncology Therapeutics, In (BBOT) at Buy
May 5, 2026 07:06 PM Form 4 BridgeBio Oncology Thera For: Apr 01 Filed by: Ben Yong
May 5, 2026 07:04 PM Form 4 BridgeBio Oncology Thera For: Apr 01 Filed by: Beltran Pedro
May 5, 2026 07:02 PM Form 4 BridgeBio Oncology Thera For: Apr 01 Filed by: Mehra Uneek
Apr 30, 2026 04:23 PM Form 3 BridgeBio Oncology Thera For: Apr 21 Filed by: Cobo Marc
Apr 30, 2026 04:21 PM Form 3 BridgeBio Oncology Thera For: Apr 20 Filed by: Elmelech Idan
View All Articles

Entities mentioned with BBOT

View All Entities